Russia Launches $26 Billion Biotechnology and Life Sciences Program

Russia has established a state-backed program valued at $26 billion to support longevity research. The initiative aims to develop methods that could extend human lifespan through scientific study.

The funding comes from Russian state resources and is described as the largest national commitment of its kind. Details of the program were discussed in an interview between The Wall Street Journal’s Chief European Political Correspondent and France 24.

” The Wall Street Journal coverage examined the background of the initiative and its stated goals. The reporting did not include specific project timelines or named research institutions. No additional outcomes or participant data were provided in the available coverage.